You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 22, 2025

Drug Price Trends for NDC 68682-0271


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 68682-0271

Drug Name NDC Price/Unit ($) Unit Date
HYDROCORTISONE BUTYR 0.1% OINT 68682-0271-15 1.87253 GM 2025-03-19
HYDROCORTISONE BUTYR 0.1% OINT 68682-0271-15 1.87253 GM 2025-02-19
HYDROCORTISONE BUTYR 0.1% OINT 68682-0271-15 1.87253 GM 2025-01-22
HYDROCORTISONE BUTYR 0.1% OINT 68682-0271-45 1.76749 GM 2024-09-18
HYDROCORTISONE BUTYR 0.1% OINT 68682-0271-15 1.99364 GM 2024-09-18
HYDROCORTISONE BUTYR 0.1% OINT 68682-0271-45 1.74348 GM 2024-08-21
HYDROCORTISONE BUTYR 0.1% OINT 68682-0271-15 1.99908 GM 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 68682-0271

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 68682-0271: Navigating the Future of Pharmaceutical Pricing

The pharmaceutical industry is constantly evolving, with drug prices and market dynamics playing a crucial role in shaping its future. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug with National Drug Code (NDC) 68682-0271, offering valuable insights for industry professionals and stakeholders.

Understanding NDC 68682-0271

Before we dive into the market analysis, it's essential to understand what NDC 68682-0271 represents. The National Drug Code is a unique, three-segment number assigned by the U.S. Food and Drug Administration (FDA) to human drugs in the United States[4]. In this case, 68682 is the labeler code, 027 is the product code, and 1 is the package code.

Drug Identification and Usage

While the search results don't provide specific information about the drug associated with NDC 68682-0271, we can infer that it's a prescription medication. The lack of direct information about this NDC suggests it might be a relatively new or less common drug in the market.

Current Market Trends in Pharmaceutical Pricing

To understand the potential price projections for NDC 68682-0271, we need to examine the broader trends in pharmaceutical pricing.

Overall Drug Price Inflation

According to Vizient, Inc., drug price inflation is projected to grow at 3.8% in the latest Pharmacy Market Outlook[2]. This increase, the highest since July 2019, is driven in part by specialty pharmaceuticals.

"Many hospitals around the country experienced a challenging 2023, including drug shortages and rising drug costs," said Carina Dolan, associate vice president, clinical oncology, pharmacoeconomics and market insights, Vizient[2].

Specialty Pharmaceuticals Leading the Charge

Specialty pharmaceuticals, which treat high-cost, complex, or chronic conditions, are expected to see a price increase of 4.18%[2]. With 42 novel specialty drugs approved in 2023 and potentially a record number of approvals in 2024, this trend is likely to continue.

Factors Influencing Drug Pricing

Several factors come into play when pharmaceutical companies set prices for their products:

1. Patent Status

The patent status of a drug significantly influences its pricing. Drugs under patent protection often command higher prices due to exclusivity in the market[7].

2. Research and Development Costs

The substantial investments made in R&D are often reflected in drug prices, especially for novel treatments.

3. Market Demand

The prevalence of the condition the drug treats and the availability of alternative treatments can impact pricing.

4. Regulatory Environment

Government policies and regulations play a crucial role in shaping drug prices.

Price Projections for NDC 68682-0271

While we don't have specific historical pricing data for NDC 68682-0271, we can make some educated projections based on industry trends:

Potential for Price Increases

If NDC 68682-0271 is a specialty drug, it may see price increases in line with or exceeding the projected 4.18% for specialty medications[2].

Impact of Market Dynamics

The drug's price trajectory will likely be influenced by factors such as its therapeutic category, competition, and market demand.

The Role of Technology in Pricing Strategies

Pharmaceutical companies are increasingly leveraging technology to optimize their pricing strategies:

AI and Data Analytics

More than 85% of biopharma executives surveyed say they are investing in data, AI, and digital tools in 2025 to build supply chain resiliency[10]. These technologies can help companies make more informed pricing decisions.

Smart Manufacturing

90% of biopharma executives are investing in smart manufacturing to increase supply chain efficiency[10]. This could potentially lead to cost savings that might influence pricing.

The Changing Landscape of Drug Development

The pharmaceutical industry is undergoing significant changes that could impact future pricing:

Novel Modalities and Mechanisms of Action

Companies are adopting new modalities and mechanisms of action, which could lead to more diverse and potentially higher-priced drug portfolios[10].

Focus on High Unmet Needs

There's an increasing shift towards therapy areas with high unmet needs, which could justify higher prices for innovative treatments[10].

Regulatory and Policy Considerations

The regulatory environment plays a crucial role in shaping drug prices:

Drug Affordability Boards

Several states have established drug affordability boards to study drug prices[1]. These initiatives could potentially impact future pricing strategies.

Policy Changes

The incoming administration's health policies, tariffs, taxes, and M&A oversight could accelerate changes in the pharmaceutical market[6].

Market Outlook for NDC 68682-0271

While specific projections for NDC 68682-0271 are challenging without more information, we can anticipate that its pricing will be influenced by:

  1. Its therapeutic category and whether it's classified as a specialty drug
  2. The overall trend of increasing drug prices, particularly for specialty medications
  3. The competitive landscape in its specific market segment
  4. Potential regulatory changes and policy initiatives

Strategies for Stakeholders

Given the complex and evolving nature of pharmaceutical pricing, stakeholders should consider the following strategies:

For Pharmaceutical Companies

  1. Invest in data analytics and AI to optimize pricing strategies
  2. Focus on developing drugs for areas with high unmet needs
  3. Prepare for potential regulatory changes and their impact on pricing

For Healthcare Providers

  1. Stay informed about drug price trends and projections
  2. Consider alternative treatments when available to manage costs
  3. Engage in negotiations with pharmaceutical companies and insurers

For Payers and Insurers

  1. Develop strategies to manage the increasing costs of specialty drugs
  2. Collaborate with pharmaceutical companies on value-based pricing models
  3. Invest in data analytics to better understand and predict drug spending trends

Key Takeaways

  1. Drug prices are projected to increase by 3.8% overall, with specialty pharmaceuticals leading at 4.18%.
  2. Technological advancements, particularly in AI and data analytics, are shaping pricing strategies.
  3. The focus on novel modalities and high unmet needs could justify higher prices for innovative treatments.
  4. Regulatory initiatives, such as drug affordability boards, may impact future pricing strategies.
  5. Stakeholders should stay informed about market trends and be prepared to adapt to the changing landscape of pharmaceutical pricing.

FAQs

  1. Q: How often are drug prices typically adjusted? A: Drug prices can be adjusted annually or more frequently, depending on various factors including market conditions, competition, and regulatory changes.

  2. Q: Can consumers influence drug pricing? A: While individual consumers have limited direct influence, collective action through advocacy groups and voting for policies that address drug pricing can have an impact.

  3. Q: How do biosimilars affect drug pricing? A: Biosimilars can help drive down prices by introducing competition to the market, similar to how generic drugs affect brand-name drug prices.

  4. Q: What role does insurance play in drug pricing? A: Insurance companies negotiate prices with pharmaceutical companies and can influence which drugs are covered, thereby affecting overall pricing and accessibility.

  5. Q: How might future technological advancements impact drug pricing? A: Advancements in AI, machine learning, and manufacturing technologies could potentially reduce drug development and production costs, which could influence pricing strategies.

Sources cited: [1] https://www.drugpatentwatch.com/p/drug-price/ndc/72603-0271 [2] https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-3-8-drug-price-increase-driven-by-specialty-pharmaceuticals [4] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory [6] https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html [7] https://www.gao.gov/assets/gao-10-201.pdf [10] https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond

Last updated: 2025-01-25

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.